CPRX FY 2025 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

CPRXCatalyst Pharmaceuticals, Inc.

$3B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$589M+19.8% YoY

Gross Profit

$502M85.2% margin

Operating Income

$258M43.8% margin

Net Income

$214M36.4% margin

EPS (Diluted)

$1.68

Cash Flow

Operating Cash Flow

$209M

Free Cash Flow

$209M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$150M

Stockholders' Equity

$954M

Cash & Equivalents

$709M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$589M	$492M	+19.8%
Gross Profit	$502M	$423M	+18.6%
Operating Income	$258M	$195M	+32.1%
Net Income	$214M	$164M	+30.8%